Trials / Conditions / Ebola Virus
Ebola Virus
6 registered clinical trials studyying Ebola Virus.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Ebola Sudan Chimpanzee Adenovirus Vector Vaccine in Healthy Adults NCT04041570 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Investigational Therapeutics for the Treatment of People With Ebola Virus Disease NCT03719586 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 / Phase 3 |
| Completed | Partnership for Research on Ebola Vaccines in Liberia (PREVAIL) NCT02344407 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola V NCT02314923 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001) NCT02269423 | Merck Sharp & Dohme LLC | Phase 1 |
| Withdrawn | An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebol NCT02271347 | Jazz Pharmaceuticals | Phase 2 |